Introduction: Cyclodestructive procedures, which target the nonpigmented epithelium of the ciliary body, have been utilized to treat recalcitrant glaucoma since the early 1930s. There are now various types of cyclophotocoagulation (CPC) available. The authors provide a retrospective description that details the histopathologic findings in 2 patients who underwent CPC for uncontrolled uveitic and neovascular glaucoma (NVG) with subsequent enucleation. Case Presentations: Two enucleated globes from 2 patients with secondary refractory glaucoma underwent cilioablative therapy: one with uveitic glaucoma and a remote history of micropulse transscleral CPC (MP-TSCPC) and the other with NVG and a recent history of traditional continuous transscleral CPC (CW-TSCPC). The clinical histories are summarized, and light microscopy reviewed for degree of coagulative necrosis and inflammation of the ciliary body and surrounding structures, as well as the underlying pathology of the glaucoma. Conclusion: Both patients ultimately experienced pain and vision loss with either a recrudescence of elevated intraocular pressure or inflammatory hypotony and subsequently underwent enucleation of the affected eye. One globe was enucleated shortly after CW-TSCPC and found to have near full-thickness coagulative necrosis of the pigmented and nonpigmented ciliary epithelium and ciliary muscle as well as necrosis of adjacent nontarget tissues with fibrin in the anterior chamber. The second patient underwent enucleation many months after MP-TSCPC with partial healing fibrosis of the ciliary body and some remaining viable ciliary processes. The histopathologic findings post-CPC may vary based on the method used and evolve over time; additional study is needed.

1.
Shields
MB
.
Cyclodestructive surgery for glaucoma: past, present, and future
.
Trans Am Ophthalmol Soc
.
1985
;
83
:
285
303
.
2.
Ndulue
JK
,
Rahmatnejad
K
,
Sanvicente
C
,
Wizov
SS
,
Moster
MR
.
Evolution of cyclophotocoagulation
.
J Ophthalmic Vis Res
.
2018
;
13
(
1
):
55
61
. .
3.
Nguyen
AT
,
Maslin
J
,
Noecker
RJ
.
Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma
.
Eur J Ophthalmol
.
2020
;
30
(
4
):
700
5
. .
4.
Sanchez
FG
,
Peirano-Bonomi
JC
,
Brossard Barbosa
N
,
Khoueir
Z
,
Grippo
TM
.
Update on micropulse transscleral cyclophotocoagulation
.
J Glaucoma
.
2020
;
29
(
7
):
598
603
. .
5.
Aquino
MC
,
Barton
K
,
Tan
AM
,
Sng
C
,
Li
X
,
Loon
SC
,
Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a Randomized Exploratory Study
.
Clin Exp Ophthalmol
.
2015
;
43
(
1
):
40
6
.
6.
Sarrafpour
S
,
Saleh
D
,
Ayoub
S
,
Radcliffe
NM
.
Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes
.
Ophthalmol Glaucoma
.
2019
;
2
(
3
):
167
71
. .
7.
Tan
AM
,
Chockalingam
M
,
Aquino
MC
,
Lim
ZI
,
See
JL
,
Chew
PT
.
Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma
.
Clin Exp Ophthalmol
.
2010
;
38
(
3
):
266
72
. .
8.
Dhanireddy
S
,
Yin
HY
,
Dosakayala
N
,
Kurochkin
P
,
Gupta
N
,
Cheng
AMS
,
Severe inflammation and hyphema after micropulse diode transscleral cyclophotocoagulation
.
J Glaucoma
.
2020
;
29
(
6
):
e50
e2
.
9.
Radhakrishnan
S
,
Wan
J
,
Tran
B
,
Thai
A
,
Hernandez-Siman
J
,
Chen
K
,
Micropulse cyclophotocoagulation: a multicenter study of efficacy, safety, and factors associated with increased risk of complications
.
J Glaucoma
.
2020
;
29
(
12
):
1126
31
.
10.
Williams
AL
,
Moster
MR
,
Rahmatnejad
K
,
Resende
AF
,
Horan
T
,
Reynolds
M
,
Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma
.
J Glaucoma
.
2018
;
27
(
5
):
445
9
.
11.
Moussa
K
,
Feinstein
M
,
Pekmezci
M
,
Lee
JH
,
Bloomer
M
,
Oldenburg
C
,
Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a Randomized Comparative Study
.
Translational Vis Sci Technol
.
2020
;
9
(
5
):
22
.
12.
Tan
NYQ
,
Ang
M
,
Chan
ASY
,
Barathi
VA
,
Tham
CC
,
Barton
K
,
Transscleral cyclophotocoagulation and its histological effects on the conjunctiva
.
Sci Rep
.
2019
;
9
(
1
):
18703
.
13.
Walland
MJ
,
McKelvie
PA
.
Diode laser cyclophotocoagulation: histopathology in two cases of clinical failure
.
Ophthalmic Surg Lasers
.
1998
;
29
(
10
):
852
6
. .
14.
de Crom
RMPC
,
Slangen
CGMM
,
Kujovic-Aleksov
S
,
Webers
CAB
,
Berendschot
TTJM
,
Beckers
HJM
.
Micropulse trans-scleral cyclophotocoagulation in patients with glaucoma: 1- and 2-Year treatment outcomes
.
J Glaucoma
.
2020
;
29
(
9
):
794
8
. .
15.
Emanuel
ME
,
Grover
DS
,
Fellman
RL
,
Godfrey
DG
,
Smith
O
,
Butler
MR
,
Micropulse cyclophotocoagulation: Initial results in refractory glaucoma
.
J Glaucoma
.
2017
;
26
(
8
):
726
9
.
16.
McKelvie
PA
,
Walland
MJ
.
Pathology of cyclodiode laser: a series of nine enucleated eyes
.
Br J Ophthalmol
.
2002
;
86
(
4
):
381
6
. .
17.
Souissi
S
,
Le Mer
Y
,
Metge
F
,
Portmann
A
,
Baudouin
C
,
Labbé
A
,
An update on continuous-wave cyclophotocoagulation (CW-CPC) and micropulse transscleral laser treatment (MP-TLT) for adult and paediatric refractory glaucoma
.
Acta Ophthalmol
.
2021
;
99
(
5
):
e621
e53
.
18.
Schlote
T
,
Beck
J
,
Rohrbach
JM
,
Funk
RH
.
Alteration of the vascular supply in the rabbit ciliary body by transscleral diode laser cyclophotocoagulation
.
Graefes Arch Clin Exp Ophthalmol
.
2001
;
239
(
1
):
53
8
. .
19.
Pantcheva
MB
,
Kahook
MY
,
Schuman
JS
,
Rubin
MW
,
Noecker
RJ
.
Comparison of acute structural and histopathological changes of the porcine ciliary processes after endoscopic cyclophotocoagulation and transscleral cyclophotocoagulation
.
Clin Exp Ophthalmol
.
2007
;
35
(
3
):
270
4
. .
20.
Sharon
Y
,
Friling
R
,
Luski
M
,
Campoverde
BQ
,
Amer
R
,
Kramer
M
.
Uveitic glaucoma: long-term clinical outcome and risk factors for progression
.
Ocul Immunol Inflamm
.
2017
;
25
(
6
):
740
7
. .
21.
Sherman
ER
,
Cafiero-Chin
M
.
Overcoming diagnostic and treatment challenges in uveitic glaucoma
.
Clin Exp Optom
.
2019
;
102
(
2
):
109
15
. .
22.
Elgin
U
,
Berker
N
,
Batman
A
.
Incidence of secondary glaucoma in behcet disease
.
J Glaucoma
.
2004
;
13
(
6
):
441
4
. .
23.
Elgin
U
,
Berker
N
,
Batman
A
,
Soykan
E
.
Trabeculectomy with mitomycin C in secondary glaucoma associated with Behçet disease
.
J Glaucoma
.
2007
;
16
(
1
):
68
72
. .
24.
Kaburaki
T
,
Koshino
T
,
Kawashima
H
,
Numaga
J
,
Tomidokoro
A
,
Shirato
S
,
Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis
.
Eye
.
2009
;
23
(
7
):
1509
17
.
25.
Shimizu
A
,
Maruyama
K
,
Yokoyama
Y
,
Tsuda
S
,
Ryu
M
,
Nakazawa
T
.
Characteristics of uveitic glaucoma and evaluation of its surgical treatment
.
Clin Ophthalmol
.
2014
;
8
:
2383
9
. .
26.
Kwon
HJ
,
Kong
YXG
,
Tao
LW
,
Lim
LL
,
Martin
KR
,
Green
C
,
Surgical outcomes of trabeculectomy and glaucoma drainage implant for uveitic glaucoma and relationship with uveitis activity
.
Clin Exp Ophthalmol
.
2017
;
45
(
5
):
472
80
.
27.
Olmos
LC
,
Lee
RK
.
Medical and surgical treatment of neovascular glaucoma
.
Int Ophthalmol Clin
.
2011
;
51
(
3
):
27
36
. .
28.
Rodrigues
GB
,
Abe
RY
,
Zangalli
C
,
Sodre
SL
,
Donini
FA
,
Costa
DC
,
Neovascular glaucoma: a review
.
Int J Retina Vitreous
.
2016
;
2
:
26
.
29.
Shen
CC
,
Salim
S
,
Du
H
,
Netland
PA
.
Trabeculectomy versus Ahmed glaucoma valve implantation in neovascular glaucoma
.
Clin Ophthalmol
.
2011
;
5
:
281
6
. .
30.
Choy
BNK
,
Lai
JSM
,
Yeung
JCC
,
Chan
JCH
.
Randomized comparative trial of diode laser transscleral cyclophotocoagulation versus Ahmed glaucoma valve for neovascular glaucoma in Chinese: a Pilot Study
.
Clin Ophthalmol
.
2018
;
12
:
2545
52
. .
31.
Yildirim
N
,
Yalvac
IS
,
Sahin
A
,
Ozer
A
,
Bozca
T
.
A Comparative Study between diode MP TSCPC laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma: a long-term follow-up
.
J Glaucoma
.
2009
;
18
(
3
):
192
6
. .
32.
Ramli
N
,
Htoon
HM
,
Ho
CL
,
Aung
T
,
Perera
S
.
Risk factors for hypotony after transscleral diode cyclophotocoagulation
.
J Glaucoma
.
2012
;
21
(
3
):
169
73
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.